Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016.

Kidney Med · 2021 · PMC8039422 · PMID 33851113

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Except for glimepiride, which showed an increasing trend from 13.2% in 2007 to 16.2% in 2016, use of other sulfonylureas decreased (eg, glyburide use decreased from 16.5% to 2.2% from 2007 to 2016; Fig 3 B).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.